SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: Dave who wrote (5107)1/4/1999 7:02:00 PM
From: Canuck Dave  Respond to of 90042
 
Thanks.... It's caveat emptor as always....

CD



To: Dave who wrote (5107)1/4/1999 7:07:00 PM
From: MARK C.  Read Replies (1) | Respond to of 90042
 
Dave , Merck may pull a rabbit out of the hat again if the data they submitted to the FDA for vioxx warrants labeling that it does not cause ulcers and is safer than aspirin. Monsanto failed to get that labeling although they will be first to market with Celebrex.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News